Prognostic assessment of breast carcinoma submitted to neoadjuvant chemotherapy with pathological non-complete response

BACKGROUND: Breast cancer with pathological non-complete response (non-pCR) after neoadjuvant chemotherapy (NAC) has a worse prognosis. Despite Neo-Bioscore has been validated as an independent prognostic model for breast cancer submitted to NAC, non-pCR carcinoma was not assessed in this setting. M...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:BMC Cancer
Asıl Yazarlar: Resende, Uanderson, Cabello, César, Ramalho, Susana Oliveira Botelho, Zeferino, Luiz Carlos
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2019
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6580604/
https://ncbi.nlm.nih.gov/pubmed/31208353
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-019-5812-0
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller